Revenue

Pfizer·Products & Services·39 segments·Rolls up to Total Revenue

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Eliquis	$1.88B	$1.62B	$1.83B	$1.92B	$2.00B	$2.02B	$2.02B	$2.17B
Prevnar Family	$1.36B	$1.80B	$1.56B	$1.66B	$1.38B	$1.74B	$1.71B	$1.69B
Vyndaqel family	$1.32B	$1.45B	$1.54B	$1.49B	$1.62B	$1.59B	$1.69B	$1.60B
Ibrance	$1.13B	$1.09B	$1.10B	$977.00M	$1.05B	$1.06B	$1.04B	$1.01B
All Other Hospital and Biosimilars	—	—	—	—	—	—	—	$953.00M
All other Primary Care	$759.00M	$742.00M	$787.00M	$609.00M	$736.00M	$721.00M	$789.00M	$654.00M
Padcev	$394.00M	$409.00M	$444.00M	$426.00M	$542.00M	$464.00M	$508.00M	$591.00M
All other Specialty Care	$429.00M	$323.00M	$344.00M	$486.00M	$390.00M	$407.00M	$476.00M	$579.00M
Xtandi	$495.00M	$561.00M	$565.00M	$458.00M	$566.00M	$578.00M	$592.00M	$444.00M
Oncology Biosimilars	$279.00M	$285.00M	$209.00M	$264.00M	$353.00M	$315.00M	$369.00M	$409.00M
Royalty	$345.00M	$384.00M	$431.00M	$308.00M	$426.00M	$436.00M	$480.00M	$396.00M
All other Oncology	$347.00M	$268.00M	$285.00M	$377.00M	$380.00M	$272.00M	$303.00M	$376.00M
Nurtec ODT/Vydura	$356.00M	$337.00M	$393.00M	$248.00M	$359.00M	$412.00M	$405.00M	$353.00M
Lorbrena	$169.00M	$206.00M	$193.00M	$222.00M	$251.00M	$268.00M	$282.00M	$305.00M
Pfizer CentreOne	$278.00M	$285.00M	$326.00M	$273.00M	$328.00M	$344.00M	$409.00M	$289.00M
Comirnaty	$195.00M	$1.42B	$3.38B	$565.00M	$381.00M	$1.15B	$2.27B	$232.00M
Inlyta	$252.00M	$247.00M	$242.00M	$219.00M	$243.00M	$226.00M	$235.00M	$214.00M
Sulperazon (Outside the U.S. and Canada)	$144.00M	$156.00M	$169.00M	$164.00M	$166.00M	$154.00M	$169.00M	$199.00M
Adcetris	$279.00M	$268.00M	$285.00M	$218.00M	$255.00M	$215.00M	$220.00M	$190.00M
Paxlovid	$251.00M	$2.70B	—	$491.00M	$427.00M	$1.23B	—	$186.00M
Inflectra	$97.00M	$126.00M	—	$153.00M	$139.00M	$173.00M	—	$182.00M
Abrysvo	$56.00M	$356.00M	$198.00M	$131.00M	$143.00M	$279.00M	$480.00M	$180.00M
Xeljanz	$303.00M	$321.00M	$350.00M	$128.00M	$322.00M	$313.00M	$324.00M	$180.00M
Braftovi/Mektovi	$148.00M	$173.00M	$170.00M	$136.00M	$182.00M	$202.00M	$197.00M	$174.00M
Zavicefta (Outside the U.S. and Canada)	$150.00M	$152.00M	$159.00M	$135.00M	$163.00M	$158.00M	$181.00M	$150.00M
Enbrel (Outside the U.S. and Canada)	$179.00M	$169.00M	$183.00M	$140.00M	$154.00M	$154.00M	$179.00M	$138.00M
Bosulif	$167.00M	$161.00M	$171.00M	$151.00M	$149.00M	$150.00M	$161.00M	$129.00M
Tukysa	$121.00M	$124.00M	$129.00M	$102.00M	$132.00M	$110.00M	$119.00M	$122.00M
Octagam	$104.00M	$221.00M	$109.00M	$88.00M	$97.00M	$113.00M	$120.00M	$122.00M
Zithromax	$74.00M	$83.00M	$123.00M	$158.00M	$56.00M	$73.00M	$113.00M	$112.00M
Orgovyx	—	—	—	—	—	$112.00M	$136.00M	$109.00M
Genotropin	$119.00M	$119.00M	$112.00M	$95.00M	$106.00M	$128.00M	$117.00M	$93.00M
FSME-IMMUN/TicoVac	$100.00M	$81.00M	$34.00M	$63.00M	$109.00M	$100.00M	$47.00M	$81.00M
Elrexfio	$22.00M	$40.00M	$57.00M	$60.00M	$85.00M	$85.00M	$74.00M	$80.00M
Cibinqo	$47.00M	$63.00M	$63.00M	$58.00M	$69.00M	$79.00M	$78.00M	$76.00M
Talzenna	$32.00M	$36.00M	$26.00M	$40.00M	$46.00M	$47.00M	$49.00M	$50.00M
Tivdak	$33.00M	$34.00M	$37.00M	$33.00M	$46.00M	$37.00M	$32.00M	$33.00M
Total	$13.28B	$17.70B	$17.76B	$13.72B	$14.65B	$16.65B	$17.56B	$14.45B

Excluding Comirnaty and Paxlovid is derived from annual filings.

Segments

ProductView metric

RoyaltyView metric

Pfizer CentreOneView metric

EliquisView metric

Prevnar FamilyView metric

Nurtec ODT/VyduraView metric

ComirnatyView metric

PaxlovidView metric

AbrysvoView metric

FSME-IMMUN/TicoVacView metric

All other Primary CareView metric

IbranceView metric

PadcevView metric

XtandiView metric

LorbrenaView metric

InlytaView metric

AdcetrisView metric

Braftovi/MektoviView metric

BosulifView metric

TukysaView metric

OrgovyxView metric

ElrexfioView metric

TalzennaView metric

TivdakView metric

All other OncologyView metric

Vyndaqel familyView metric

XeljanzView metric

Zavicefta (Outside the U.S. and Canada)View metric

Enbrel (Outside the U.S. and Canada)View metric

OctagamView metric

GenotropinView metric

CibinqoView metric

All other Specialty CareView metric

Oncology BiosimilarsView metric

Sulperazon (Outside the U.S. and Canada)View metric

InflectraView metric

ZithromaxView metric

All Other Hospital and BiosimilarsView metric

Excluding Comirnaty and PaxlovidView metric

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Eliquis	$1.88B	$1.62B	$1.83B	$1.92B	$2.00B	$2.02B	$2.02B	$2.17B
Prevnar Family	$1.36B	$1.80B	$1.56B	$1.66B	$1.38B	$1.74B	$1.71B	$1.69B
Vyndaqel family	$1.32B	$1.45B	$1.54B	$1.49B	$1.62B	$1.59B	$1.69B	$1.60B
Ibrance	$1.13B	$1.09B	$1.10B	$977.00M	$1.05B	$1.06B	$1.04B	$1.01B
All Other Hospital and Biosimilars	—	—	—	—	—	—	—	$953.00M
All other Primary Care	$759.00M	$742.00M	$787.00M	$609.00M	$736.00M	$721.00M	$789.00M	$654.00M
Padcev	$394.00M	$409.00M	$444.00M	$426.00M	$542.00M	$464.00M	$508.00M	$591.00M
All other Specialty Care	$429.00M	$323.00M	$344.00M	$486.00M	$390.00M	$407.00M	$476.00M	$579.00M
Xtandi	$495.00M	$561.00M	$565.00M	$458.00M	$566.00M	$578.00M	$592.00M	$444.00M
Oncology Biosimilars	$279.00M	$285.00M	$209.00M	$264.00M	$353.00M	$315.00M	$369.00M	$409.00M
Royalty	$345.00M	$384.00M	$431.00M	$308.00M	$426.00M	$436.00M	$480.00M	$396.00M
All other Oncology	$347.00M	$268.00M	$285.00M	$377.00M	$380.00M	$272.00M	$303.00M	$376.00M
Nurtec ODT/Vydura	$356.00M	$337.00M	$393.00M	$248.00M	$359.00M	$412.00M	$405.00M	$353.00M
Lorbrena	$169.00M	$206.00M	$193.00M	$222.00M	$251.00M	$268.00M	$282.00M	$305.00M
Pfizer CentreOne	$278.00M	$285.00M	$326.00M	$273.00M	$328.00M	$344.00M	$409.00M	$289.00M
Comirnaty	$195.00M	$1.42B	$3.38B	$565.00M	$381.00M	$1.15B	$2.27B	$232.00M
Inlyta	$252.00M	$247.00M	$242.00M	$219.00M	$243.00M	$226.00M	$235.00M	$214.00M
Sulperazon (Outside the U.S. and Canada)	$144.00M	$156.00M	$169.00M	$164.00M	$166.00M	$154.00M	$169.00M	$199.00M
Adcetris	$279.00M	$268.00M	$285.00M	$218.00M	$255.00M	$215.00M	$220.00M	$190.00M
Paxlovid	$251.00M	$2.70B	—	$491.00M	$427.00M	$1.23B	—	$186.00M
Inflectra	$97.00M	$126.00M	—	$153.00M	$139.00M	$173.00M	—	$182.00M
Abrysvo	$56.00M	$356.00M	$198.00M	$131.00M	$143.00M	$279.00M	$480.00M	$180.00M
Xeljanz	$303.00M	$321.00M	$350.00M	$128.00M	$322.00M	$313.00M	$324.00M	$180.00M
Braftovi/Mektovi	$148.00M	$173.00M	$170.00M	$136.00M	$182.00M	$202.00M	$197.00M	$174.00M
Zavicefta (Outside the U.S. and Canada)	$150.00M	$152.00M	$159.00M	$135.00M	$163.00M	$158.00M	$181.00M	$150.00M
Enbrel (Outside the U.S. and Canada)	$179.00M	$169.00M	$183.00M	$140.00M	$154.00M	$154.00M	$179.00M	$138.00M
Bosulif	$167.00M	$161.00M	$171.00M	$151.00M	$149.00M	$150.00M	$161.00M	$129.00M
Tukysa	$121.00M	$124.00M	$129.00M	$102.00M	$132.00M	$110.00M	$119.00M	$122.00M
Octagam	$104.00M	$221.00M	$109.00M	$88.00M	$97.00M	$113.00M	$120.00M	$122.00M
Zithromax	$74.00M	$83.00M	$123.00M	$158.00M	$56.00M	$73.00M	$113.00M	$112.00M
Orgovyx	—	—	—	—	—	$112.00M	$136.00M	$109.00M
Genotropin	$119.00M	$119.00M	$112.00M	$95.00M	$106.00M	$128.00M	$117.00M	$93.00M
FSME-IMMUN/TicoVac	$100.00M	$81.00M	$34.00M	$63.00M	$109.00M	$100.00M	$47.00M	$81.00M
Elrexfio	$22.00M	$40.00M	$57.00M	$60.00M	$85.00M	$85.00M	$74.00M	$80.00M
Cibinqo	$47.00M	$63.00M	$63.00M	$58.00M	$69.00M	$79.00M	$78.00M	$76.00M
Talzenna	$32.00M	$36.00M	$26.00M	$40.00M	$46.00M	$47.00M	$49.00M	$50.00M
Tivdak	$33.00M	$34.00M	$37.00M	$33.00M	$46.00M	$37.00M	$32.00M	$33.00M
Total	$13.28B	$17.70B	$17.76B	$13.72B	$14.65B	$16.65B	$17.56B	$14.45B

Excluding Comirnaty and Paxlovid is derived from annual filings.